Feb 14, 2019 7:00am EST Nemus Bioscience Signs Agreement with Pharmaceuticals International Inc. to Develop Dosage Formulation for Human Dosing with NB1111 for Glaucoma
Jan 23, 2019 7:30am EST Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum
Jan 03, 2019 7:00am EST Nemus Bioscience to Present at the 2nd Annual Sach’s Neuroscience Innovation Forum and Biotech Showcase 2019
Nov 29, 2018 3:51pm EST Nemus Bioscience to Present at Investment and Scientific Conferences in December
Oct 08, 2018 8:00am EDT Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares
Aug 28, 2018 8:00am EDT NEMUS Bioscience to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
Aug 01, 2018 9:54am EDT UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
